{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:20:27Z","timestamp":1790619627389,"version":"4.1.0"},"reference-count":31,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2010,2,9]],"date-time":"2010-02-09T00:00:00Z","timestamp":1265673600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Haemophilia"],"published-print":{"date-parts":[[2010,7]]},"abstract":"<jats:p><jats:bold>Summary.\u2002<\/jats:bold> The aim of this study was to evaluate the use of limited blood sampling and Bayesian analysis to estimate the pharmacokinetics (PK) and tailor the dose of factor VIII (FVIII) in an individual patient. In a Bayesian analysis, PK parameters are estimated from only a few plasma concentration measurements, using a previously established PK model. First the necessary model was created using intense blood sampling FVIII data from 10 patients. Then FVIII data from another 21 patients were used for \u2018clinical\u2019 evaluation. Three scenarios were created retrospectively by reduction of the original 7\u2010sample data set; blood sampling at 4, 24 and 48\u2003h, at 8 and 30\u2003h and at 24\u2003h after the infusion. PK parameters were estimated for each individual using Bayesian analysis and compared with those obtained using conventional methods from the full data. The accuracy of predictions of FVIII levels during prophylactic treatment 5\u201317\u2003months later and implications for dose tailoring were also investigated. Blood sampling at 4, 24 and 48\u2003h was found to give practically the same PK information as a full, conventional (7\u201310\u2010sample) study. Even a single 24\u2010h FVIII level provided adequate data for initial dose tailoring and gave predictions of FVIII levels 5\u201317\u2003months later that were not appreciably worse than predictions based on the full PK analysis. By contrast, dose tailoring based on body weight failed completely. In conclusion, PK\u2010based dose tailoring of FVIII can be performed using limited blood sampling during prophylactic treatment.<\/jats:p>","DOI":"10.1111\/j.1365-2516.2009.02191.x","type":"journal-article","created":{"date-parts":[[2010,2,10]],"date-time":"2010-02-10T03:07:49Z","timestamp":1265771269000},"page":"597-605","source":"Crossref","is-referenced-by-count":102,"title":["Limited blood sampling for pharmacokinetic dose tailoring of FVIII in the prophylactic treatment of haemophilia A"],"prefix":"10.1111","volume":"16","author":[{"given":"S.","family":"BJ\u00d6RKMAN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,6,21]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1993.tb00638.x"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.1997.00091.x"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200140110-00003"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.9.s1.4.x"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2005.01149.x"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1962.tb04185.x"},{"key":"e_1_2_6_8_2","first-page":"1","article-title":"Haemophilia in Sweden. VII. Incidence, treatment and prophylaxis of arthropathy and other musculo\u2010skeletal manifestations of haemophilia A and B","volume":"77","author":"Ahlberg \u00c5","year":"1965","journal-title":"Acta Orthopaedica Scand"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.1976.tb16525.x"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.1992.tb00546.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.1995.tb00103.x"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2796.1997.130135000.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.1998.440409.x"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2004.01036.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2008.03270.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2001.00471.x"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.2002.00694.x"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1646423"},{"key":"e_1_2_6_19_2","unstructured":"LeeM MorfiniM SchulmanS IngerslevJandthe Factor VIII\/Factor IX Scientific and Standardization Committee of the International Society for Thrombosis and Haemostasis(2001)The design and analysis of pharmacokinetic studies of coagulation factors. Available athttp:\/\/www.isth.org\/Publications\/OfficialCommunications\/Factor8and9\/Pharmacokinetic.aspx(accessed July 12 2009)."},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1351-8216.2002.00136.x"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2006.01253.x"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1979263294"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200140110-00002"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ftd.0000211810.19935.44"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199222060-00004"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0010-468X(85)90008-X"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-198713060-00002"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199222050-00005"},{"issue":"40","key":"e_1_2_6_29_2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1600-0609.1984.tb02556.x","article-title":"Assay of factor VIII:C with a chromogenic substrate","volume":"33","author":"Ros\u00e9n S","year":"1984","journal-title":"Scand J Haematol"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-009-0676-x"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2006.01334.x"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199325030-00004"}],"container-title":["Haemophilia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2516.2009.02191.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2516.2009.02191.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T02:51:02Z","timestamp":1698634262000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2516.2009.02191.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,21]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["10.1111\/j.1365-2516.2009.02191.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2516.2009.02191.x","archive":["Portico"],"relation":{},"ISSN":["1351-8216","1365-2516"],"issn-type":[{"value":"1351-8216","type":"print"},{"value":"1365-2516","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,21]]}}}